{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:05:13Z","timestamp":1793754313089,"version":"4.6.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82470914"],"award-info":[{"award-number":["82470914"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82330023"],"award-info":[{"award-number":["82330023"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["92457301"],"award-info":[{"award-number":["92457301"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09972-6","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:52:25Z","timestamp":1775325145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Palmitoleic acid promoted by BMPR2 signaling primes CD169 macrophages and alleviates liver fibrosis"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-0406","authenticated-orcid":false,"given":"Hong","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danchun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-4682","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-047X","authenticated-orcid":false,"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1226-097X","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-7425","authenticated-orcid":false,"given":"Qi-qun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-8908","authenticated-orcid":false,"given":"Shuwen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"9972_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W.-S. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021).","journal-title":"Lancet"},{"key":"9972_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9972_CR3","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.jhep.2023.08.008","volume":"79","author":"TG Simon","year":"2023","unstructured":"Simon, T. G., Roelstraete, B., Hagstr\u00f6m, H., Loomba, R. & Ludvigsson, J. F. Progression of non-alcoholic fatty liver disease and long-term outcomes: a nationwide paired liver biopsy cohort study. J. Hepatol. 79, 1366\u20131373 (2023).","journal-title":"J. Hepatol."},{"key":"9972_CR4","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe, R. F., Tabas, I. & Pajvani, U. B. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158, 1913\u20131928 (2020).","journal-title":"Gastroenterology"},{"key":"9972_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","volume":"68","author":"D Schuppan","year":"2018","unstructured":"Schuppan, D., Surabattula, R. & Wang, X. Y. Determinants of fibrosis progression and regression in NASH. J. Hepatol. 68, 238\u2013250 (2018).","journal-title":"J. Hepatol."},{"key":"9972_CR6","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl, A. M. & Day, C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N. Engl. J. Med. 377, 2063\u20132072 (2017).","journal-title":"N. Engl. J. Med."},{"key":"9972_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","volume":"18","author":"Y Wen","year":"2021","unstructured":"Wen, Y., Lambrecht, J., Ju, C. & Tacke, F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell. Mol. Immunol. 18, 45\u201356 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"9972_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov, K. et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 145\u2013159 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9972_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","volume":"53","author":"S Tran","year":"2020","unstructured":"Tran, S. et al. Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity 53, 627\u2013640.e5 (2020).","journal-title":"Immunity"},{"key":"9972_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","volume":"121","author":"S Ganguly","year":"2024","unstructured":"Ganguly, S. et al. Lipid-associated macrophages\u2019 promotion of fibrosis resolution during MASH regression requires TREM2. Proc. Natl. Acad. Sci. USA 121, e2405746121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9972_CR11","doi-asserted-by":"publisher","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","volume":"34","author":"S Daemen","year":"2021","unstructured":"Daemen, S. et al. Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH. Cell Rep 34, 108626 (2021).","journal-title":"Cell Rep"},{"key":"9972_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","volume":"53","author":"A Remmerie","year":"2020","unstructured":"Remmerie, A. et al. Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver. Immunity 53, 641\u2013657.e14 (2020).","journal-title":"Immunity"},{"key":"9972_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512\u2013518 (2019).","journal-title":"Nature"},{"key":"9972_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add8945","volume":"8","author":"T Fabre","year":"2023","unstructured":"Fabre, T. et al. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci. Immunol. 8, eadd8945 (2023).","journal-title":"Sci. Immunol."},{"key":"9972_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby, E., Chen, P. & Aouadi, M. Macrophage functional diversity in NAFLD - more than inflammation. Nat. Rev. Endocrinol. 18, 461\u2013472 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"9972_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.tem.2024.04.009","volume":"35","author":"R Xu","year":"2024","unstructured":"Xu, R. et al. Lipid-associated macrophages between aggravation and alleviation of metabolic diseases. Trends Endocrinol. Metab. TEM 35, 981\u2013995 (2024).","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"9972_CR17","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran, P. et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. USA 109, E3186\u2013E3195 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9972_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038\u20131048 (2016).","journal-title":"Metabolism"},{"key":"9972_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2015.11.005","volume":"27","author":"D Yadin","year":"2016","unstructured":"Yadin, D., Knaus, P. & Mueller, T. D. Structural insights into BMP receptors: specificity, activation and inhibition. Cytokine Growth Factor Rev. 27, 13\u201334 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"9972_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/path.5170","volume":"247","author":"MC Gomez-Puerto","year":"2019","unstructured":"Gomez-Puerto, M. C. et al. Bone morphogenetic protein receptor signal transduction in human disease. J. Pathol. 247, 9\u201320 (2019).","journal-title":"J. Pathol."},{"key":"9972_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gendis.2014.07.005","volume":"1","author":"RN Wang","year":"2014","unstructured":"Wang, R. N. et al. Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes Dis. 1, 87\u2013105 (2014).","journal-title":"Genes Dis."},{"key":"9972_CR22","doi-asserted-by":"publisher","first-page":"a021899","DOI":"10.1101\/cshperspect.a021899","volume":"8","author":"T Katagiri","year":"2016","unstructured":"Katagiri, T. & Watabe, T. Bone morphogenetic proteins. Cold Spring Harb. Perspect. Biol. 8, a021899 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"9972_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/path.4833","volume":"241","author":"L Ma","year":"2017","unstructured":"Ma, L. & Chung, W. K. The role of genetics in pulmonary arterial hypertension. J. Pathol. 241, 273\u2013280 (2017).","journal-title":"J. Pathol."},{"key":"9972_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","volume":"141","author":"S Rosenkranz","year":"2020","unstructured":"Rosenkranz, S., Howard, L. S., Gomberg-Maitland, M. & Hoeper, M. M. Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation 141, 678\u2013693 (2020).","journal-title":"Circulation"},{"key":"9972_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1164\/rccm.201903-0656CI","volume":"201","author":"NP Nickel","year":"2020","unstructured":"Nickel, N. P. et al. Beyond the lungs: systemic manifestations of pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 201, 148\u2013157 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9972_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","volume":"34","author":"M Nikolaou","year":"2013","unstructured":"Nikolaou, M. et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur. Heart J. 34, 742\u2013749 (2013).","journal-title":"Eur. Heart J."},{"key":"9972_CR27","doi-asserted-by":"publisher","first-page":"204589402110543","DOI":"10.1177\/20458940211054304","volume":"11","author":"NP Nickel","year":"2021","unstructured":"Nickel, N. P. et al. Liver abnormalities in pulmonary arterial hypertension. Pulm. Circ. 11, 20458940211054304 (2021).","journal-title":"Pulm. Circ."},{"key":"9972_CR28","doi-asserted-by":"publisher","first-page":"106238","DOI":"10.1016\/j.phrs.2022.106238","volume":"180","author":"R-R Wang","year":"2022","unstructured":"Wang, R.-R. et al. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective. Pharmacol. Res. 180, 106238 (2022).","journal-title":"Pharmacol. Res."},{"key":"9972_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCRESAHA.122.321554","volume":"132","author":"I Cuthbertson","year":"2023","unstructured":"Cuthbertson, I., Morrell, N. W. & Caruso, P. BMPR2 mutation and metabolic reprogramming in pulmonary arterial hypertension. Circ. Res. 132, 109\u2013126 (2023).","journal-title":"Circ. Res."},{"key":"9972_CR30","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi, K. et al. Transcriptomics Identify thrombospondin-2 as a biomarker for NASH and advanced liver fibrosis. Hepatology 74, 2452\u20132466 (2021).","journal-title":"Hepatology"},{"key":"9972_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jcmgh.2022.12.008","volume":"15","author":"T Chen","year":"2023","unstructured":"Chen, T. et al. Hepatocyte smoothened activity controls susceptibility to insulin resistance and nonalcoholic fatty liver disease. Cell. Mol. Gastroenterol. Hepatol. 15, 949\u2013970 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"9972_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","volume":"18","author":"M Ahrens","year":"2013","unstructured":"Ahrens, M. et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 18, 296\u2013302 (2013).","journal-title":"Cell Metab."},{"key":"9972_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell. Proteomics MCP 13, 397\u2013406 (2014).","journal-title":"Mol. Cell. Proteomics MCP"},{"key":"9972_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2010.10.006","volume":"50","author":"JA Shayman","year":"2011","unstructured":"Shayman, J. A., Kelly, R., Kollmeyer, J., He, Y. & Abe, A. Group XV phospholipase A\u2082, a lysosomal phospholipase A\u2082. Prog. Lipid Res. 50, 1\u201313 (2011).","journal-title":"Prog. Lipid Res."},{"key":"9972_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3892\/br.2020.1402","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Xia, Y. & Qiu, C.-H. Functions of CD169 positive macrophages in human diseases (Review). Biomed. Rep. 14, 26 (2021).","journal-title":"Biomed. Rep."},{"key":"9972_CR36","first-page":"465","volume":"13","author":"M Okuda","year":"1981","unstructured":"Okuda, M., Takenaka, T., Kawabori, S. & Ogami, Y. Ultrastructural study of the specific granule of the human eosinophil. J. Submicrosc. Cytol. 13, 465\u2013471 (1981).","journal-title":"J. Submicrosc. Cytol."},{"key":"9972_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41374-018-0069-9","volume":"98","author":"Y-H Chung","year":"2018","unstructured":"Chung, Y.-H. et al. BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-\u03b21 signaling. Lab. Investig. J. Tech. Methods Pathol. 98, 999\u20131013 (2018).","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"9972_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102794","volume":"56","author":"NE Owen","year":"2020","unstructured":"Owen, N. E. et al. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis. EBioMedicine 56, 102794 (2020).","journal-title":"EBioMedicine"},{"key":"9972_CR39","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.3748\/wjg.v25.i30.4222","volume":"25","author":"G-L Zou","year":"2019","unstructured":"Zou, G.-L. et al. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-\u03b2\/Smad signaling pathway. World J. Gastroenterol. 25, 4222\u20134234 (2019).","journal-title":"World J. Gastroenterol."},{"key":"9972_CR40","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s42255-020-0214-9","volume":"2","author":"M Vacca","year":"2020","unstructured":"Vacca, M. et al. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nat. Metab. 2, 514\u2013531 (2020).","journal-title":"Nat. Metab."},{"key":"9972_CR41","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1007\/s10620-007-9758-8","volume":"52","author":"F Tacke","year":"2007","unstructured":"Tacke, F. et al. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig. Dis. Sci. 52, 3404\u20133415 (2007).","journal-title":"Dig. Dis. Sci."},{"key":"9972_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41420-022-01011-7","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis. Cell Death Discov 8, 234 (2022).","journal-title":"Cell Death Discov"},{"key":"9972_CR43","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.18632\/aging.102552","volume":"11","author":"Q Peng","year":"2019","unstructured":"Peng, Q. et al. Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes. Aging 11, 11520\u201311540 (2019).","journal-title":"Aging"},{"key":"9972_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jcp.20593","volume":"207","author":"J Fan","year":"2006","unstructured":"Fan, J. et al. Bone morphogenetic protein 4 mediates bile duct ligation induced liver fibrosis through activation of Smad1 and ERK1\/2 in rat hepatic stellate cells. J. Cell. Physiol. 207, 499\u2013505 (2006).","journal-title":"J. Cell. Physiol."},{"key":"9972_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7150\/ijms.5765","volume":"10","author":"L Zhong","year":"2013","unstructured":"Zhong, L. et al. The anti-fibrotic effect of bone morphogenic protein-7(BMP-7) on liver fibrosis. Int. J. Med. Sci. 10, 441\u2013450 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"9972_CR46","doi-asserted-by":"publisher","first-page":"238150","DOI":"10.1155\/2013\/238150","volume":"2013","author":"S Tang","year":"2013","unstructured":"Tang, S. et al. Association of genetic variants of BMP4 with type 2 diabetes mellitus and clinical traits in a Chinese Han population. BioMed Res. Int. 2013, 238150 (2013).","journal-title":"BioMed Res. Int."},{"key":"9972_CR47","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s42003-020-0928-y","volume":"3","author":"S Qian","year":"2020","unstructured":"Qian, S. et al. BMPR2 promotes fatty acid oxidation and protects white adipocytes from cell death in mice. Commun. Biol. 3, 200 (2020).","journal-title":"Commun. Biol."},{"key":"9972_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ebiom.2016.07.034","volume":"11","author":"S-W Qian","year":"2016","unstructured":"Qian, S.-W. et al. BMP4 cross-talks with estrogen\/ER\u03b1 signaling to regulate adiposity and glucose metabolism in females. EBioMedicine 11, 91\u2013100 (2016).","journal-title":"EBioMedicine"},{"key":"9972_CR49","doi-asserted-by":"publisher","first-page":"E798","DOI":"10.1073\/pnas.1215236110","volume":"110","author":"S-W Qian","year":"2013","unstructured":"Qian, S.-W. et al. BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc. Natl. Acad. Sci. USA 110, E798\u2013E807 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9972_CR50","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1194\/jlr.RA120000869","volume":"61","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. SCD1 promotes lipid mobilization in subcutaneous white adipose tissue. J. Lipid Res. 61, 1589\u20131604 (2020).","journal-title":"J. Lipid Res."},{"key":"9972_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.immuni.2010.12.011","volume":"34","author":"K Asano","year":"2011","unstructured":"Asano, K. et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34, 85\u201395 (2011).","journal-title":"Immunity"},{"key":"9972_CR52","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.celrep.2016.07.010","volume":"16","author":"P Gupta","year":"2016","unstructured":"Gupta, P. et al. Tissue-resident CD169(+) macrophages form a crucial front line against plasmodium infection. Cell Rep 16, 1749\u20131761 (2016).","journal-title":"Cell Rep"},{"key":"9972_CR53","doi-asserted-by":"publisher","first-page":"979373","DOI":"10.3389\/fmed.2022.979373","volume":"9","author":"S Herzog","year":"2022","unstructured":"Herzog, S., Fragkou, P. C., Arneth, B. M., Mkhlof, S. & Skevaki, C. Myeloid CD169\/Siglec1: an immunoregulatory biomarker in viral disease. Front. Med. 9, 979373 (2022).","journal-title":"Front. Med."},{"key":"9972_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah5520","volume":"2","author":"OA Perez","year":"2017","unstructured":"Perez, O. A. et al. CD169+ macrophages orchestrate innate immune responses by regulating bacterial localization in the spleen. Sci. Immunol. 2, eaah5520 (2017).","journal-title":"Sci. Immunol."},{"key":"9972_CR55","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/1440-1681.12736","volume":"44","author":"CO Souza","year":"2017","unstructured":"Souza, C. O. et al. Palmitoleic acid reduces the inflammation in LPS-stimulated macrophages by inhibition of NF\u03baB, independently of PPARs. Clin. Exp. Pharmacol. Physiol. 44, 566\u2013575 (2017).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"9972_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158776","volume":"1865","author":"CO Souza","year":"2020","unstructured":"Souza, C. O. et al. Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-\u03b3-independent M2a polarization of myeloid cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1865, 158776 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"9972_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2014.06.010","volume":"393","author":"NA Talbot","year":"2014","unstructured":"Talbot, N. A., Wheeler-Jones, C. P. & Cleasby, M. E. Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance. Mol. Cell. Endocrinol. 393, 129\u2013142 (2014).","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09972-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:04:03Z","timestamp":1780445043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09972-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9972"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09972-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"749"}}